Drugs / Autologous Stem Cells
Autologous Stem Cells
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02038972 | Jan 2013 → Dec 2015 | sensorineural hearing loss disorder | James Baumgartner, MD | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT01834079 | Sep 2014 → Jul 2016 | optic atrophy | Chaitanya Hospital, Pune | Unknown | No outcome recorded |
| Phase 1/2 | NCT01786707 | Jul 2009 → Mar 2011 | type 2 diabetes mellitus | Rodolfo Alejandro | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT03829566 | Nov 2019 → Jan 2025 | neuromyelitis optica | Northwestern University | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT03593902 | May 2018 → Oct 2019 | systemic sclerosis | Northwestern University | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01648491 | Oct 2011 → Jul 2012 | female stress incontinence | Kenneth Peters, MD | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00346177 Comparator | Sep 2010 → Sep 2011 | congestive heart failure, myocardial ischemia | Losordo, Douglas, M.D. | Withdrawn | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT05675319 Comparator | Mar 2023 → Mar 2025 | plasma cell myeloma | University Medical Center Hamburg-Eppendorf | Terminated | No outcome recorded |
| Phase 3 | NCT03342638 Background | Nov 2017 → Jul 2019 | relapsing-remitting multiple sclerosis | Northwestern University | Terminated | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Stem Cells | “Autologous stem cells(MNCs ) intra thecal .Intra thecal transplantation of single arm autologous MNCs 100 millions per dose in 3 divided doses at interval of 7...” NCT01834079 ↗ |
| Known as | ASC | “This is a phase I/II, prospective, randomized case controlled study in patients with Type 2 Diabetes Mellitus (T2DM) that seeks to investigate whether the combination of...” NCT01786707 ↗ |
| Known as | autologous MNCs | “Autologous stem cells(MNCs ) intra thecal .Intra thecal transplantation of single arm autologous MNCs 100 millions per dose in 3 divided doses at interval of 7...” NCT01834079 ↗ |
| Modality | Cell therapy | “cell therapy with your own cells (autologous cells)” NCT00346177 ↗ |
| Route | Other | “Intramyocardial injections” NCT00346177 ↗ |